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Abstract
As an addictive substance, nicotine has been suggested to facilitate pro-survival activities (such as anchorage-independent
growth or angiogenesis) and the establishment of drug resistance to anticancer therapy. Tobacco smoking consists of a
variety of carcinogens [such as benzopyrene (BP) and nitrosamine derivatives] that are able to cause DNA double strand
breaks. However, the effect of nicotine on DNA damage-induced checkpoint response induced by genotoxins remains
unknown. In this study, we investigated the events occurred during G1 arrest induced by c-radiation or BP in nicotine-
treated murine or human lung epithelial cells. DNA synthesis was rapidly inhibited after exposure to c-radiation or BP
treatment, accompanied with the activation of DNA damage checkpoint. When these cells were co-treated with nicotine,
the growth restriction was compromised, manifested by upregulation of cyclin D and A, and attenuation of Chk2
phosphorylation. Knockdown of cyclin D or Chk2 by the siRNAs blocked nicotine-mediated effect on DNA damage
checkpoint activation. However, nicotine treatment appeared to play no role in nocodazole-induced mitotic checkpoint
activation. Overall, our study presented a novel observation, in which nicotine is able to override DNA damage checkpoint
activated by tobacco-related carcinogen BP or c-irradiation. The results not only indicates the potentially important role of
nicotine in facilitating the establishment of genetic instability to promote lung tumorigenesis, but also warrants a dismal
prognosis for cancer patients who are smokers, heavily exposed second-hand smokers or nicotine users.
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Introduction
Tobacco smoke imposes a high risk for human malignancies,
especially for lung cancer, because it contains more than 4000
components, most of which are well defined carcinogens [1,2]. For
example, benzopyrene or NNK/NNN [4-(methylnitrosamino)-1-
(3-pyridyl)-1-butanone/N9-nitrosonornicotine) are the carcinogens
in tobacco smoke and known to cause the generation of DNA
adducts or mutating growth-related genes (like p53 or ras) [3–6].
Although Nicotine is a major component in tobacco smoke and
exists in high concentrations in the smokers, its function has been
well documented as an addictive substance affecting the central
nerve system [7,8]. Recently, studies demonstrated that nicotinic
acetylcholine receptor (nAChR) expresses in various types of non-
neuronal cells, such as lung, mammary epithelial or vascular
endothelial cells [9–11]. Nicotine, via interacting with the
receptor, was shown to promote cell growth and angiogenesis in
in vitro or in vivo experimental models [12–14].
DNA damage threats to cells because it may cause mutations,
alterations of chromosomal structures and loss of genetic
information. Cells possess a machinery to maintain the genomic
integrity in response to genostresses [15,16]. Under genotoxic
conditions, cells do not progress into S or M phase before lesions
are properly repaired by activating DNA damage checkpoint
[15,16]. The reduction of the sensitivity to genotoxic agents closely
links to loss of the checkpoint function that permits cells a high rate
of genomic adaptation to acquire a growth advantage. DNA
damage checkpoint acts as a process of signal transduction to
transmit information from damaged lesions to cell cycle regulators.
In this process, ATM for double strand DNA breaks and ATR for
single strand damages appear to be activated and further mediates
a cascade of protein phosphorylation of effector checkpoint kinases
(including Chk1 and Chk2) [17–20]. Under the influence of these
checkpoint regulators, cells arrest at the G1/S or G2/M phases of
the cell cycle, respectively [20,21]. Although many components in
tobacco smoke have been proved to be genotoxic, the combination
effect of nicotine and tobacco-related genotoxic reagents or
therapeutic radiation on DNA damage response remains unex-
plored.
Inhibition of the activity of cyclin D complexes is the key event
to govern the G1/S checkpoint in cells [22,23]. In this process, a
rapid but transient response is elicited following cdc25A
degradation, whereas a p21 or p53-mediated signaling supports
a sustained reaction [22,23]. After DNA double strand breaks, the
ATM-mediated DNA damage checkpoint pathway is activated by
autophosphorylation and activation of ATM, which in turn,
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several effector proteins, including phosphatases of the cdc25
family or BRCA1 [24,25]. Dephosphorylation of cdc25A
promotes the transition of cells from G1/S by removing the
inhibitory phosphates on the cdk2/cyclinE complex [24,25]. In
the activation of DNA damage checkpoint, the phosphorylation of
cdc25A by Chk2 causes its degradation, which blocks the function
of G1/S regulators, leading to growth arrest [24,25].
The irradiation with c ray has been implemented clinically to
treat patients suffered from various types of malignancies. Some of
these patients are smokers, heavily exposed second-hand smokers
and those using nicotine for smoking cessation or pain relief.
Benzopyrene is a well-established carcinogen by forming DNA
adducts and further DNA double strand breaks and co-exists with
nicotine in tobacco smoking. Thus, there is an urgent need for the
understanding of the influence of nicotine on DNA damage
checkpoint response triggered by c-irradiation or BP exposure. In
this study, we investigated the role of nicotine on the G1 arrest
initiated by genostress in human or murine lung epithelial cells.
We showed that the activation of DNA damage response was
compromised by the concurrent treatment of nicotine with c-
radiation or BP treatment, through the upregulation of cyclin D1
as well as the attenuation of Chk2 activation. However, the
treatment with nicotine appeared to play no role in G2/M phase
checkpoints. Our data strongly suggest that nicotine is capable of
overriding the DNA damage checkpoint activation, thereby
potentially increasing risk of cancer genesis or progression via
disrupting genetic surveillance.
Results
Nicotine exposure interferes with DNA damage-induced
G1/S arrest
Nicotine is an addictive substance and has been shown to
rapidly activate several extracellular, mitogenic-related pathways
for growth promotion [26–28]. Since most of tobacco smoke
components are genotoxic, we first tested the influence of nicotine
on genotoxic stress in murine LA4 or human BEAS-2B lung
epithelial cells. [
3H]-thymidine incorporation assay was per-
formed (Fig. 1a). After serum starvation, the cells were exposed
to c-irradiation (5 Gy), or treated with BP (benzolpyrene,
200 ng/ml) or nicotine (0.5 mM) for 4 h. Subsequently, the rate
of [
3H]-thymidine incorporation of the cells was analyzed. A very
low baseline level of [
3H]-thymidine incorporation was seen in
serum starved, irradiated or BP-treated cells. The intake of [
3H]-
thymidine was dramatically upregulated after serum-starved cells
were re-fed with the growth medium containing 10% serum
(about 8–10 folds). In comparison, the rate of [
3H]-thymidine
incorporation was moderately increased in the cells treated with
nicotine under serum starvation condition (about 3 folds). The
similar effect of nicotine on [
3H]-thymidine incorporation was
observed in irradiated or BP-treated cells. The pictures of cell
cultures, upon c-irradiation in the presence or absence of
nicotine, were taken by the phase contrast photography
(Fig. 1b). Consistently, there is a few proliferating LA4 or
BEAS-2B cells in the cultures. The addition of nicotine promoted
some of irradiated or BP-treated cells to divide. The data suggest
Figure 1. Effect of nicotine exposure on the growth of human or murine lung epithelial BEAS-2B and LA4 cells. a. Cells were grown in
the medium containing 0.5% serum for 24 h, and then subjected to various treatments. Four hours later, the rate of [
3H] incorporation was measured
by a scintillation counter. Error bars represent the standard deviation over 5 independent experiments (n=5, p,0.05). b. The phase contrast photos
of the cells with the treatments as indicated. c. Four hour after the treatments as described above, Annexin V assay was performed to evaluate cell
viability or occurrence of apoptosis. Error bars represent the standard deviation over 5 independent experiments (n=5, p,0.05).
doi:10.1371/journal.pone.0018619.g001
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growth arrest.
To eliminate the possibility that the lack of DNA synthesis
might be due to the induction of apoptosis, the viability of the cells,
after being treated with BP treatment for 4 h or exposed to c-
irradiation, was determined by Annexin V assay (fig. 1c). The
results revealed that the majority of treated BEAS-2B or LA4 cells
were viable at the time when the assay was performed, and only a
few cells stained positively with Annexin V.
Nicotine disrupts the negative effect of DNA damage on
G1/S regulators
It is known that DNA damage causes growth arrest that is
resulted from negative controls on G1/S regulators [24,25].
Therefore, the effect of nicotine on DNA damage-mediated
growth restriction was tested. The expression of cyclin D1, E or A
was analyzed after c-irradiation or BP treatment in the presence or
absence of nicotine (Fig. 2a). A relatively high level of cyclin D1
was detected in BEAS-2B cells, which was slightly upregulated by
nicotine treatment. The amount of the expression of this cell cycle
regulator was significantly reduced after the irradiation or BP
treatment (about 3.5–4 folds). However, cyclin D1 expression did
not change in the cells co-treated with nicotine plus radiation or
BP. The results indicate that nicotine might, via altering the
expression of cyclin D1, lift DNA damage-induced growth
restriction, and function as a rate limiting factor of the G1
restriction in nicotine-mediated cell cycle progression.
Cyclin A is an important and necessary factor in controlling the
transition or progression of cells from G1 to S phase. Therefore,
the expression of cyclin A was examined by immunoblotting
(Fig. 2b). Again, a low level of cyclin A was present in irradiated
or BP-treated cells, which was increased by the co-treatment with
nicotine (about 3 folds), suggesting that cyclin A is also a rate
limiting factor in nicotine-mediated interference with c-irradia-
tion- or BP-induced growth restriction. However, the co-treatment
had no effect on cyclin E expression.
c-radiation- or BP-mediated Chk2 activation is blocked by
nicotine exposure
In response to genotoxic damage, Chk1 and Chk2 are
phosphorylated by the upstream ATR or ATM kinase, respec-
tively [17–19]. Since nicotine perturbed radiation- or BP-induced
growth arrest, the phosphorylation status of Chk2 and Chk1 in
BEAS-2B cells was examined by immunoblotting (Fig. 3). Chk2
was phosphorylated after the cells were exposed to c-radiation or
treated with BP and nicotine treatment alone played no role in
Chk1 phosphorylation. However, the co-treatment of nicotine
with the radiation or BP, the phosphorylated Chk2 in the cells
became undetectable. The similar change of Chk2 phosphoryla-
tion after the co-treatment was also observed in murine lung
epithelial LA4 cells (data not shown). In contrast, a baseline level
of phosphorylated Chk1 was present in BEAS-2B cells following c-
irradiation or BP-treatment, and the co-treatment did not alter the
phosphorylation pattern of this checkpoint. Thus, the data suggest
that the phosphorylation of Chk2 (but not Chk1), elicited by the
genotoxic stresses, was interfered by nicotine treatment.
Nicotine treatment plays no role in nocodazole-mediated
G2/M phase checkpoint
Nocodazole arrests cells in G2/M phase through disrupting
microtubules of the nucleus by associating with b-tubulin and
preventing the formation of the interchain disulfide linkages [29].
We tested whether the activation of nocodazole-mediated G2/M
checkpoints upon BP treatment was compromised by nicotine.
After being arrested in the M phase of the cell cycle by
nocodazole, BEAS-2B or LA4 cells were treated with BP or its
combination with nicotine and cell cycle distribution was
measured by a flow cytometer (Fig. 4a). As expected, the majority
of BEAS-2B cells were arrested in the G2/M phases of the cell
Figure 2. Expression of G1 cyclins in irradiated or BP-treated
BEAS-2B cells in the presence or absence of nicotine. a. Cells
were irradiated with c-ray or treated with BP in the presence or absence
of nicotine. Subsequently, cell lysates were prepared and immuno-
blotted with anti-cyclin D1 antibody. Even loading of total proteins was
normalized by re-probing the nitrocellulose with anti-b-actin antibody.
b. The expression of cyclin E or A after the same treatments as
described above. Even loading of total proteins was normalized by re-
probing with anti-b-actin antibody.
doi:10.1371/journal.pone.0018619.g002
Figure 3. Phosphorylation status of Chk2 and Chk1 in
irradiated or BP-treated BEAS-2B cells in the presence or
absence of nicotine. a. Cells were irradiated with c-ray or treated
with BP in the presence or absence of nicotine. Subsequently, cell
lysates were prepared and immunoblotted with the anti-phos-Chk2
antibody. Even loading of total proteins was normalized by re-probing
with anti-b-actin antibody. b. The expression of the phosphorylated
Chk1 after the same treatments as described above. Even loading of
total proteins was normalized by re-probing with anti-b-actin antibody.
doi:10.1371/journal.pone.0018619.g003
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treatment with BP or its combination with nicotine had no effect
on nocodazole-induced enrichment of G2/M population of BEAS-
2B or LA4 cells.
BubR1 and cyclin B1 are key M phase regulators [30–32]. We
next examined their activation status or expression. BubR1 was
not phospohorylated in untreated BEAS-2B cells (Fig. 4b). After
c-irradiation, the phosphoyrlation form of BubR1 was present in
nocodazole-treated BEAS-2B cells, the level of which did not
change after the addition of nicotine. Consistently, upon
irradiation, the level of cyclin B1 in nocodazole-treated BEAS-
2B cells was higher than that in untreated cells, and nicotine
treatment did not reduce the amount of cyclin B1 expression.
Furthermore, the expression of cdc2 that forms a complex with
cyclin B1 during G2/M transition was examined by immunoblot-
ting. The similar pattern of the expression of this G2/M regulator
as cyclin B1 was detected in irradiated BEAS-2B cells with or
without nicotine treatment. It appears that nicotine had no role in
M checkpoints.
Knockdown of cyclin D1 or Chk2 abrogates the effect of
nicotine on growth arrest induced by DNA damage
The experiments demonstrated above indicated a potentially
important action of nicotine in perturbing the activation of G1/S
checkpoints induced by c-irradiation or BP treatment. To further
determine this, shRNAs were used and then tested the knockdown
Figure 4. Effect of nicotine on G2/M phases in BP-treated BEAS-2B cells. a. BEAS-2B cells were treated nocodazole prior being treated with
BP in the presence or absence of nicotine. Subsequently, cells were fixed and stained with propidium iodide. The percentage of G2/M phase
population was measured by a flow cytometer. Error bars represent the standard deviation over 5 independent experiments (n=5, p,0.05). b. After
the same treatments as described above, cell lysates were prepared and immunoblotting was performed to test the expression of BubR1/p-BubR1,
cyclin B1 and cdc2. Even loading of total proteins was normalized by re-probing the nitrocellulose with anti-b-actin antibody.
doi:10.1371/journal.pone.0018619.g004
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cells. ShRNA-cyclinD1 and shRNA-Chk2, but not scRNA-cyclinD1 and
scRNA-Chk2, efficiently knocked down the expression of these two
kinases in BEAS-2B cells (Fig. 5a). ShRNA-Chk1 also successfully
suppressed Chk1 expression (data not shown). Subsequently, the
influence of nicotine on the rate of [
3H]-thymidine incorporation
in BEAS-2B cells with or without knockdown of cyclinD1, Chk2 or
Chk1 or overexpression of cyclinD1 was tested following c-
irradiation or treatment with BP (Fig. 5b). Again, after the
exposure to c-irradiation or BP treatment, the intake of [
3H]-
thymidine in BEAS-2B cells was almost absent. A moderate
amount of [
3H]-thymidine was incorporated into the genome of
irradiated- or BP-treated cells after the addition of nicotine (3–4
folds), which was further augmented by the overexpression of
cyclinD1 (6–7 folds). In contrast, knockdown of cyclinD1 or Chk2 by
the shRNAs (but not the scRNAs) completely blocked this nicotine-
mediated [
3H]-thymidine intake. The infection of scRNA-Chk1 or
shRNA-Chk1 had no effect on nicotine-mediated incorporation,
suggesting little role for Chk1 in the perturbation of G1/S
checkpoints elicited by c-irradiation or BP treatment.
Discussion
In this study, we have investigated the mechanism by which
nicotine perturbs c-irradiation- or BP treatment-induced G1/S
checkpoints. We showed that the addition of nicotine interfered
with the inhibition of DNA synthesis induced by c-irradiation or
BP treatment, concomitant with the upregulation of cyclin D1 and
A as well as abrogation of the phosphorylated form of Chk2.
Furthermore, block of cyclin D1 or Chk2 signaling abolished the
nicotine-mediated effect on DNA damage-induced growth restric-
tion. These results are in agreement with our previous studies
showing that long term exposure of nicotine perturbed Rb/E2F
signaling pathway to promote cell proliferation [14,33]. Using
xenograft assay, other groups also demonstrated that nicotine was
able to promote various lung cancer cell lines to form tumors in
nude mice [12–14]. Collectively, our current data identified that
cyclin D1 and Chk2 are intracellular targets of nicotine for the
dysregulation of G1/S phase checkpoints activated by c-irradia-
tion- or BP-induced DNA damage. Further consistent with a role
of the loss of the function of Chk2 in the disruption of G1/S
checkpoints, both Chk2 phosphorylation and growth arrest
induced by the radiation and BP treatment were prevented by
nicotine exposure.
Nicotine is often used to aid smoking cessation or relieve chronic
pain. The use of nicotine has been associated with the promotion
of tumorigenesis in lung or other organs [34]. Studies demon-
strated that nicotine exposure has pro-survival activity in lung
epithelial cells, by activating various intracellular growth factors,
such as PKC, or by upregulating Bcl-2 activity to antagonize
apoptotic signals [35]. Using mouse models, studies also showed
that nicotine stimulated angiogenesis in the settings of inflamma-
tion, ischemia, atherosclerosis and tumor growth [9–11]. Upon the
interaction between nicotine and its receptor, MAP kinase activity
was upregulated via a tyrosine kinase pathway. Furthermore, Akt
in primary human airway epithelial cells was activated in response
to transient exposure to nicotine. This effect has been suggested to
contribute to tobacco-related carcinogenesis [36]. In response to
persistent exposure to nicotine, cyclin D1 has been shown to be
enhanced via the activation of Ras signaling and further forced
cells to progress under the mitogen withdrawal condition. Our
current study suggests that cyclin D1 is the primary target of
Figure 5. DNA synthesis of irradiated or BP-treated BEAS-2B cells after knockdown of cyclin D1, Chk2 or Chk1 upon nicotine
exposure. scRNA-, siRNA-clnD1, scRNA- or siRNAChk2 was introduced in to the cells and subsequently, the knockdown of cln D1 and Chk2 expression
were analyzed by immunoblotting (upper panels). After the knockdown of clnD1, Chk1 or Chk2, the cells with various treatments were measured for
[
3H] incorporation. Error bars represent the standard deviation over 5 independent experiments (n=5, p,0.05).
doi:10.1371/journal.pone.0018619.g005
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but also in the disruption of G1/S checkpoints.
BP forms adducts with DNA that causes DNA double strand
breaks through generating DNA single strand nucleotide excision
repair intermediates. Thus, BP or c-irradiation mediated DNA
damage is likely to activate ATM-governed checkpoints, which
was also confirmed by our findings that Chk2 was phosphorylated
in response to the exposure to the radiation and BP treatment. It is
possible that nicotine, through promoting cyclin D1/E2F
signaling, prevents ATM/Chk2 signaling to be activated or
interferes with Chk2 phosphorylation process in response to
DNA double strand damage induced by either c-irradiation or BP,
and further perturbs the growth restriction.
Studies demonstrated that in nicotine-mediated growth promo-
tion, the ligation of nicotine receptor activated Ras signaling,
which further mobilized Raf/MAP kinases [32,37,38]. Using
various promoter mutant constructs of cyclin D1, it was shown that
AP1 site, but not Ets sites, was required for nicotine-induced cyclin
D1 promoter activation. However, the molecular mechanisms of
signaling pathways bridging nicotine-mediated cyclin D1 activa-
tion and its growth promotion are not fully understood yet. Here,
we demonstrated the deregulation of cyclin D1, A and Chk2 by
nicotine in irradiated or BP-treated lung cells. It is conceivable that
different mechanisms for the activation of cyclins and suppression
of Chk2 activity are involved in nicotine-mediated growth
promotion and perturbation of G1/S checkpoint induced by
DNA damage (such as c-irradiation and BP treatment). The
studies of the underlying mechanisms are under way.
Our current study provided a particularly interesting observa-
tion that the exposure to nicotine appears to compromise the
activation of G1/S checkpoints elicited by c-irradiation or BP
treatment, but not to G2/M checkpoints. Clinical and epidemi-
ological studies suggest that first-hand or heavily exposed second-
hand smokers have more progressive and metastatic cancers than
that in non-smokers [2]. The incidences of the metastasis of breast
cancers to the lung in smokers are much higher than non-smokers
[11]. Our current data suggest that the alteration of G1/S
checkpoint response to DNA damage by nicotine is highly relevant
in this context. Indeed, others have demonstrated that persistent
exposure to nicotine resulted in the downregulation of E-cadherin
and b-catenin with concomitant increase of fibronectin and
vimentin [11]. It has also been reported through clinical studies
that smoking reduced the expression level of E-cadherin in lung
tumors, which might be responsible for the establishment of the
resistance to conventional chemotherapy [11]. From our study, it
is conceivable that apart from the role in epithelial-mesenchymal
transition or metastasis, this cigarette component takes part in the
perturbation of DNA damage-regulated checkpoint response
triggered by BP (one of carcinogens in tobacco smoking) or by
c-radiation.
In summary, we have identified a new mechanism by which
nicotine interferes with DNA damage-induced G1/S checkpoints. Our
study also provided an insight into the cooperation of the components
of cigarette smoking in lung carcinogenesis, because a high
concentration of nicotine co-exists with various tobacco carcinogens,
such as BP. Our findings also warrant the mechanism for cancer
patients who are smokers, heavily exposed second-hand smokers or
nicotine users to develop the resistance to radiation therapy.
Materials and Methods
Cell lines and treatments
All cell lines were obtained from ATCC (the American Type
Culture Collection, Mamassas, VA). The cells were cultured in the
medium according to the protocols provided by ATCC.
Benzopyrene and nocodazole were purchased from Sigma.
DNA synthesis analysis
Cells were cultured in 60-mm Petri dishes in the presence of
15 nCi/ml [
14C] thymidine (Amersham) to label DNA for 48 h. The
cells were fed with fresh medium containing [
14C] thymidine for
another 24 h. Subsequently, the cells were irradiated or treated with
DNA damage agents. One hours after irradiation or treatment, the
cells were cultured in fresh medium containing [
3H]-methyl
thymidine (5 mCi/ml) (New England Nuclear) for 4 h. Afterward,
the cells were washed with ice-cold 5% trichloro-acetic acid and
solubilized in 0.3 N NaOH. The solubilized material was transferred
to a scintillation vial and neutralized with 0.1 ml of glacial acetic acid.
The
3Ha n d
14C radioactivity in the samples was measured by dual-
channel liquid scintillation counting (49). The relative rates of DNA
synthesis were determined by
3Hc p m :
14Cc p mr a t i o .
Colony formation assay
After radiations or treatments, cells (500 cells/per dish) were
plated in the 100 mm-Petri dishes and cultured in the growth
medium for 10–14 days. Colonies were stained with Giemsa
(Sigma).
Cell Cycle Analysis
Cell cycle distribution of DNA content was measured using a
flow cytometer as described (50). The cells, after the treatments,
were fixed in 65% DME medium and 35% ethanol for 2–4 h at
4uC and stained with propidium iodide. Subsequently, the DNA
profiles were analyzed using Cell Quest software.
Immunoblotting analysis
After treatments, proteins in cell lysates were separated by SDS-
PAGE gels and then transferred to nitrocelluloses. The mem-
branes were incubated with the designated primary antibody
overnight in a cold-room at 4uC. Bound primary antibodies were
reacted with corresponding second antibodies for 2 h and detected
by chemiluminescence.
Annexin V-FITC apoptosis detection assay
After treatments, cells were prepared and stained with Annexin
V-FITC Apoptosis Detection Kit I (BD Biosciences) according to
manufacturer’s instructions. Subsequently, the samples were
analyzed by a flow cytometer.
Reproducibility
All data are representative of experiments that were performed
for more than three times.
Statistics
Three to five independent repeats were conducted in all
experiments. Error bars represent these repeats. A Student’s T test
was used and a p value of ,0.05 was considered significant.
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